Preferred Name |
cefamandole nafate |
Synonyms |
cefamandole nafate, monosodium salt, 14C-labeled, (6R-(6alpha,7beta,(R*)))-isomer |
ID |
http://purl.bioontology.org/ontology/MESH/C012810 |
altLabel |
cefamandole nafate, monosodium salt, 14C-labeled, (6R-(6alpha,7beta,(R*)))-isomer Mandol cefamandole nafate, monosodium salt, (6R-(6alpha,7beta(R*)))-isomer |
cui |
C0700924 C0889210 C0054995 C0889209 |
Has mapping qualifier | |
HM |
D002435/Q000031 |
Inverse of RB |
8HDO7941DO 64166-17-2 42540-40-9 |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19770101 |
MeSH Frequency |
36 |
MMR |
20141103 |
notation |
C012810 |
PA |
D000900 |
PI |
*CEFAMANDOLE/analogs (78-83) *CEPHALOSPORINS (77-78) |
prefLabel |
cefamandole nafate |
RR |
42540-40-9 (14C-labeled cpd mono-Na salt(6R-(6alpha,7beta,(R*)))-isomer) 64166-17-2 (mono-Na salt(6R-(6alpha,7beta(R*)))-isomer) 57268-80-1 |
SC |
1 |
Scope Statement |
RN given refers to (6R-(6alpha,7beta(R*)))-isomer |
SRC |
J Infect Dis 137:551;1978 (Suppl) Antimicrob Ag Chemother 10(3):457;1976 Antimicrob Ag Chemother 12(1):67;1977 J Pharm Sci 66(3):389;1977 J Infect Dis 137:517;1978 (Suppl) |
TERMUI |
T341976 T090090 T518986 T341975 |
TH |
FDA SRS (2015) NLM (1977) USAN (19XX) NLM (2002) INN (19XX) |
tui |
T109 T195 T130 |